Ali Poyan Mehr, M.D., is the Founding President of the GlomCon Foundation, a nonprofit charitable 501(c)(3) organization providing medical education and enabling platforms for kidney disease research. He completed his medical degree at Charité Universitätsmedizin in Berlin and postdoctoral research training at Yale University. Dr. Poyan Mehr completed his residency in internal medicine and fellowship in nephrology at the Beth Israel Deaconess Medical Center in Boston and joined the Faculty, serving as the Medical Director of Quality Improvement and Patient Safety in Nephrology at Beth Israel Deaconess Medical Center, where he led population health efforts for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). In this role, Dr. Poyan Mehr contributed to numerous innovative projects, such as developing the electronic KidneyTracker decision support system for CKD patients and receiving a Clinical Innovation Grant to help primary care physicians manage patients with chronic kidney disease. He received the Wyss Clinical Fellowship for his contributions to the biomedical engineering of microfluidics organs-on-chips development. Dr. Poyan Mehr served as the Principal Investigator, Co-Investigator, or scientific member on several Phase 1, Phase 2, and Phase 3 studies of new therapeutics for patients with kidney or cardiovascular disease, some of which were published in the New England Journal of Medicine and Nature Medicine. Dr. Poyan Mehr is currently leading a Phase 2 randomized, placebo-controlled trial, funded by the National Heart, Lung, and Blood Institute, in patients with acute kidney injury, involving more than 350 participants. He is the Director of the Regional Glomerular Disease Program at Kaiser Permanente Northern California and the Quality Lead for National Kidney Care Services at Kaiser Permanente, as well as the Medical Director of Metyos, a startup focused on bio-wearable devices.